en
svPress releases
Regulatory press release 2023-05-30
Xspray has published prospectus relating to its previously announced rights issue
Regulatory press release 2023-05-30
The Board of Directors of Xspray has resolved on a previously announced rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch
Regulatory press release 2023-05-25
Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)
Regulatory press release 2023-05-16
Bulletin from the 2023 annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2023-05-04
Interim Report First Quarter 2023
Regulatory press release 2023-05-02
Notice of extraordinary general meeting in Xspray Pharma AB (publ)
Regulatory press release 2023-05-02
Xspray announces a rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch
Regulatory press release 2023-04-13
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2023-03-29
Xspray Pharma publishes its Annual Report 2022
Regulatory press release 2023-02-23